The rapid pathway proceeds through sequential dithiol/disulfide exchanges between the active site cysteines, while the slow pathway proceeds through the more concerted action of DsbB cysteines before releasing oxidized DsbA from the DsbB-DsbA complex. The commitment steps for the two pathways are supposed to be in the nucleophilic attacks (shown by red arrows) by Cys33 of DsbA (rapid pathway) and by Cys130 of DsbB (slow pathway) of the respective target cysteines (DsbA Cys30 and DsbB Cys41, respectively), as described in our previous paper (Inaba et al, 2005). During these processes, DsbB-bound UQ undergoes the electronic transition ascribed to the Cys44-UQ CT complex formation (Inaba et al, 2006b) as shown by color change of UQ. This figure originated from Inaba et al. (2005) but is slightly modified based on the content of this paper.
contoured at 3.0σ are shown in blue. The positions of selenium signals that appeared upon V120M and C130M mutations are shown by red asterisks with residue numbers in the right two panels. Membrane fractions were prepared from cells overproducing indicated DsbB variants, as described previously (Bader et al, 1998) . 10 µM of reduced DsbA was reacted with the membrane at 30 °C in 50 mM Tris, pH8.1, 0.1 M NaCl, in which concentrations of membrane-integrated DsbB proteins were unified to 100 nM. The reaction was quenched by the addition of final 5 % of TCA at the indicated times. Samples were then subjected to pellet-down, acetone wash, AMS modification and SDS-PAGE (12.5 %). Redox state of DsbA was visualized by CBB staining. Whereas Ala-substitutions for Leu114 and Leu116 and Leu-substitutions for Val120, Val123 and Phe124 did not affect DsbA oxidation activity of DsbB, the other mutations grossly impaired the functionality of DsbB. 
